Armas Pharmaceuticals COVID-19 Statement

Monday, March 16, 2020 Drug News
Email Print This Page Comment bookmark
Font : A-A+

MANALAPAN, N.J., March 16, 2020 /PRNewswire/ -- In our role as a U.S. Healthcare Provider, Armas Pharmaceuticals Inc. (Armas) is working diligently with our international partners during the current global health emergency.

Armas is taking steps to ensure that our products are consistently available in our supply channel to help any shortages caused by the current pandemic, COVID-19.  We will also continue to closely monitor stocking levels at our logistics provider. In addition, Armas is in contact with our supply chain partners, group purchasing organizations, wholesalers and distributors to oversee where we can assist in providing our pharmaceutical products.

Currently, we do not expect any product disruptions. We will continue to provide the convenience, cost-savings, sustainability and consistency to our customers throughout this crisis.

About Armas Pharmaceuticals Inc.Armas Pharmaceuticals is a generic pharmaceutical company delivering an ever-growing portfolio of high-quality products that provide convenience, affordability and consistency.  Through the development of strong partnerships and industry relationships, Armas maintains this pipeline of products with customer and patient satisfaction in mind. Headquartered in Manalapan, New Jersey, Armas Pharmaceuticals is always open to new partnership opportunities and ways to offer our customers the best products at affordable prices. For more information, please visit ArmasPharmaceuticals.com.

Contact: Jenifer ArabiaDirector, Sales & Marketing732-637-1717235997@email4pr.com

Cision View original content:http://www.prnewswire.com/news-releases/armas-pharmaceuticals-covid-19-statement-301023173.html

SOURCE Armas Pharmaceuticals



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store